Prevention of abortion by ciclosporin treatment of fulminant ulcerative colitis during pregnancy
- Response to Jackson et al. Tursi, Antonio; Papa, Alfredo // American Journal of Gastroenterology;Mar2011, Vol. 106 Issue 3, p547
A response by Antonio Tursi and Alfredo Papa to a letter to the editor regarding their article "Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL# 3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study" in the...
- Early aggressive therapy for severe extensive ulcerative colitis. De-Jun Cui; Stocchi, Luca // World Journal of Gastroenterology;9/7/2009, Vol. 15 Issue 33, p4218
The current ulcerative colitis (UC) treatment algorithm involves a step-up therapeutic strategy, mainly aiming at inducing and maintaining its clinical remission. Although this therapeutic strategy may seem to be cost-efficient and reduce the risk of side effects, recent trials and case reports...
- Focusing on the medical needs can blind us to the full picture. Ryan, Bridget // Nursing Standard;1/13/2010, Vol. 24 Issue 19, p32
A letter to the editor is presented in response to the severe ulcerative colitis learning zone article by Mark Sephton in the December 16, 2009 issue.
- RESPONSE TO OBSERVATIONS ON SEVERE ULCERATIVE COLITIS. // Nursing Standard;1/20/2010, Vol. 24 Issue 20, p33
The article presents a response by author Mark Sephton to letters to the editor about his article concerning the management of patients with ulcerative colitis in the December 16, 2010 issue.
- Mesalamine enema-induced exacerbation of ulcerative colitis. Bousseaden, A.; Ajana, F. Z.; Essamri, W.; Benelbarhdadi, I.; Afifi, R.; Benazzouz, M.; Essaid, A. // International Journal of Colorectal Disease;Nov2009, Vol. 24 Issue 11, p1359
A letter to the editor is presented regarding the exacerbation of chronic ulcerative colitis with oral or rectal mesalamine preparations.
- VSL#3 and Remission in Active Ulcerative Colitis: Larger Studies Required. Jackson, Emma L.; Hamlin, P. John; Ford, Alexander C. // American Journal of Gastroenterology;Mar2011, Vol. 106 Issue 3, p547
A letter to the editor is presented in response to the article "Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL #3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study," by A. Tursi and colleagues in the 2010...
- Controlled-release mesalamine maintains remission in ulcerative colitis. // Modern Medicine;Jul95, Vol. 63 Issue 7, p52
Presents an abstract of the article titled `Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis,' by P. Miner, S. Hanauer, M. Robinson et al originally published in the February 1995 issue of `Digest of Diseases in Science.'
- Soothe gut feelings. Munson, Marty; Yeykal, Teresa A. // Prevention;Aug94, Vol. 46 Issue 8, p36
States that new research suggests that `the patch' used by smokers may also be used to treat ulcerative colitis (UC). How it works is a bit of a mystery, but one theory suggests it may increase a natural anti-inflammatory hormone, called cortisol; Report in `New England Journal of Medicine,'...
- Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Laharie, D. // Inflammatory Bowel Disease Monitor;2013, Vol. 13 Issue 3, p121
A review of the article "Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomized controlled trial," by D. Laharie and colleagues, which appeared in the 2012 issue of "Groupe d'Etudes ThÃ©rapeutiques des...